LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY

Urologic Clinics of North America - Tập 28 Số 3 - Trang 555-565 - 2001
Misop Han1, Alan W. Partin1, Charles R. Pound2, Jonathan I. Epstein1,3, Patrick C. Walsh1
1James Buchanan Brady Urological Institute, Departments of Urology (MH, AWP, JIE, PCW)
2Department of Urology, University of Tennessee College of Medicine, Memphis, Tennessee (CRP)
3Pathology (JIE), The Johns Hopkins Medical Institutions, Baltimore, Maryland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Beahrs, 1992

Catalona, 1994, 5-Year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer [see comments], J Urol, 152, 1837, 10.1016/S0022-5347(17)32397-2

Catalona, 1998, Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: Intermediate-term results, J Urol, 160, 2428, 10.1097/00005392-199812020-00012

Epstein, 1996, Prediction of progression following radical prostatectomy: A multivariate analysis of 721 men with long-term follow-up, Am J Surg Pathol, 20, 286, 10.1097/00000478-199603000-00004

Epstein, 1993, Correlation of pathologic findings with progression after radical retropubic prostatectomy, Cancer, 71, 3582, 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO;2-Y

Gleason, 1977, Histologic grading and clinical staging of carcinoma of the prostate., 171

Kattan, 1999, Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer, J Clin Oncol, 17, 1499, 10.1200/JCO.1999.17.5.1499

Ohori, 1994, Can radical prostatectomy alter the progression of poorly differentiated prostate cancer [see comments]?, J Urol, 152, 1843, 10.1016/S0022-5347(17)32398-4

Partin, 1993, Serum PSA after anatomic radical prostatectomy: The Johns Hopkins experience after 10 years, Urol Clin North Am, 20, 713, 10.1016/S0094-0143(21)00924-1

Pound, 1999, Natural history of progression after PSA elevation following radical prostatectomy [see comments], JAMA, 281, 1591, 10.1001/jama.281.17.1591

Pound, 1997, Prostate-specific antigen after anatomic radical retropubic prostatectomy: Patterns of recurrence and cancer control, Urol Clin North Am, 24, 395, 10.1016/S0094-0143(05)70386-4

Ramos, 1999, Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer, J Urol, 161, 1525, 10.1016/S0022-5347(05)68944-6

Reiner, 1979, An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery, J Urol, 121, 198, 10.1016/S0022-5347(17)56718-X

Stamey, 2000, Prostate cancer is highly predictable: A prognostic equation based on all morphological variables in radical prostatectomy specimens [in process citation], J Urol, 163, 1155, 10.1016/S0022-5347(05)67713-0

Trapasso, 1994, The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy [see comments], J Urol, 152, 1821, 10.1016/S0022-5347(17)32394-7

Walsh, 1998, The natural history of localized prostate cancer: A guide to therapy., 2539

Walsh, 1982, Impotence following radical prostatectomy: Insight into etiology and prevention, J Urol, 128, 492, 10.1016/S0022-5347(17)53012-8

Zincke, 1994, Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer [see comments], J Urol, 152, 1850, 10.1016/S0022-5347(17)32399-6